MHC class II expression is suppressed by TLR2 activation on microglia, limits CD4+ T cell-dependent antitumor immunity, diminishes the antigen presentation ability of microglia, and enhances the immunosuppressive profile of the tumor microenvironment (142). The gene discussed is TLR2; the disease is neoplasm.